efavirenz has been researched along with Anxiety in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (90.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, J; Li, B; Liu, Y; Xiao, J; Zhang, L; Zhao, H | 1 |
| Abbasian, L; Ahmadi, M; Ghaeli, P; Khalili, H | 1 |
| Acurcio, FA; Bonolo, PF; Ceccato, MDGB; Costa, JO; Pearson, SA; Silveira, MR | 1 |
| Grintjes-Huisman, K; Keuter, M; Koopmans, P; Mothapo, KM; Schellekens, A; van Crevel, R; van der Ven, A | 1 |
| Gaida, R; Godman, B; Grobler, C; Kotze, T; Truter, I | 1 |
| Antunes, AM; Caixas, U; Correia, MJ; Diogo, LN; Grilo, NM; Harjivan, SG; Marques, MM; Monteiro, EC; Pereira, SA; Sequeira, C | 1 |
| Felton-Coleman, A; Fletcher, CV; Owen, A; Podany, AT; Robertson, K; Sandkovsky, U; Swindells, S; Winchester, LC | 1 |
| Cavalcante, GI; Chaves Filho, AJ; de Carvalho Lima, CN; de França Fonteles, MM; de Souza, FC; Linhares, MI; Macêdo, D; Rios, ER; Vasconcelos, SM; Venâncio, ET | 1 |
| Andrade, VM; Boeck, CR; Castro, AA; de Chaves, G; Gavioli, EC; Lemos, JC; Moreira, J; Moretti, M; Quevedo, J; Romão, PR | 1 |
| Chassany, O; Costagliola, D; Lavignon, M; Potard, V; Spire, B | 1 |
1 review(s) available for efavirenz and Anxiety
| Article | Year |
|---|---|
A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications.
Topics: Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Cyclopropanes; Depression; Dizziness; HIV Infections; Humans; Sleep Wake Disorders | 2016 |
2 trial(s) available for efavirenz and Anxiety
| Article | Year |
|---|---|
Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial.
Topics: Adult; Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Cyclopropanes; Depression; Double-Blind Method; Female; HIV Infections; Humans; Hypnotics and Sedatives; Male; Patient Compliance; Pilot Projects; Valerian | 2017 |
Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment.
Topics: Adult; Alkynes; Anxiety; Benzoxazines; Cyclopropanes; Depression; Female; Follow-Up Studies; HIV Infections; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; Withholding Treatment; Young Adult | 2015 |
7 other study(ies) available for efavirenz and Anxiety
| Article | Year |
|---|---|
Anxiety, depression, and sleep disturbances among people on long-term efavirenz-based treatment for HIV: a cross-sectional study in Beijing, China.
Topics: Anxiety; Beijing; Cross-Sectional Studies; Depression; HIV Infections; Humans; Sleep; Sleep Wake Disorders | 2022 |
Health-related quality of life among HIV-infected patients initiating treatment in Brazil in the single-tablet regimen era.
Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Anxiety; Benzoxazines; Brazil; Cyclopropanes; Depression; Drug Combinations; Female; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Oxazines; Piperazines; Pyridones; Quality of Life; Surveys and Questionnaires; Tablets | 2019 |
Efavirenz biotransformation as an up-stream event of mood changes in HIV-infected patients.
Topics: Adult; Alkynes; Anti-HIV Agents; Anxiety; Benzoxazines; Biomarkers, Pharmacological; Biotransformation; Blood-Brain Barrier; Case-Control Studies; CD4 Lymphocyte Count; Cyclopropanes; Drug Monitoring; Drug Therapy, Combination; Feasibility Studies; Glucuronides; HIV Infections; Humans; Male; Metabolic Detoxication, Phase II; Middle Aged; Mood Disorders; Neurotoxicity Syndromes; Prevalence; Reverse Transcriptase Inhibitors | 2016 |
Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.
Topics: Aged; AIDS Dementia Complex; Alkynes; Anxiety; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Cytochrome P-450 CYP2B6; Depression; Female; HIV Infections; Humans; Male; Middle Aged; Neuropsychological Tests; Pharmacogenetics; Plasma; Polymorphism, Genetic; Reverse Transcriptase Inhibitors; Sleep Wake Disorders | 2017 |
HIV antiretroviral drug Efavirenz induces anxiety-like and depression-like behavior in rats: evaluation of neurotransmitter alterations in the striatum.
Topics: Alkynes; Animals; Anti-HIV Agents; Anxiety; Benzoxazines; Cyclopropanes; Depression; Male; Maze Learning; Neostriatum; Neurotransmitter Agents; Rats; Rats, Wistar; Time Factors | 2017 |
Anti-HIV drugs nevirapine and efavirenz affect anxiety-related behavior and cognitive performance in mice.
Topics: Alkynes; Animals; Anti-HIV Agents; Anxiety; Benzoxazines; Cognition; Cyclopropanes; Exploratory Behavior; Male; Mice; Nevirapine | 2011 |
Better health-related quality of life after switching from a virologically effective regimen to a regimen containing efavirenz or nevirapine.
Topics: Adult; Aged; Alkynes; Anxiety; Benzoxazines; Cyclopropanes; Depression; Female; France; Health Status; HIV Infections; Humans; Male; Middle Aged; Nevirapine; Prospective Studies; Quality of Life; Reverse Transcriptase Inhibitors; Surveys and Questionnaires; Treatment Outcome; Viral Load; Young Adult | 2010 |